PureTech Health plc (NASDAQ:PRTC – Get Free Report) shares saw unusually-strong trading volume on Thursday . Approximately 4,944 shares changed hands during trading, an increase of 63% from the previous session’s volume of 3,031 shares.The stock last traded at $22.90 and had previously closed at $21.70.
PureTech Health Price Performance
The firm’s 50 day moving average price is $22.61 and its two-hundred day moving average price is $25.82.
Hedge Funds Weigh In On PureTech Health
A hedge fund recently bought a new stake in PureTech Health stock. AWM Investment Company Inc. purchased a new stake in shares of PureTech Health plc (NASDAQ:PRTC – Free Report) in the first quarter, according to the company in its most recent filing with the SEC. The fund purchased 6,900 shares of the company’s stock, valued at approximately $197,000. 0.04% of the stock is currently owned by institutional investors and hedge funds.
About PureTech Health
PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies.
Further Reading
- Five stocks we like better than PureTech Health
- About the Markup Calculator
- Emerging Markets: What They Are and Why They Matter
- Industrial Products Stocks Investing
- Recession or Not, These 3 Stocks Are Winners
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Why NVIDIA Is More of a Screaming Buy Than Ever
Receive News & Ratings for PureTech Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PureTech Health and related companies with MarketBeat.com's FREE daily email newsletter.
